82 related articles for article (PubMed ID: 2762664)
1. [Clinical study of picotamide in patients with vascular diseases].
Speziale F; Taurino M; Colella E; Rizzo L; Fiorani P
Recenti Prog Med; 1989 May; 80(5):271-5. PubMed ID: 2762664
[TBL] [Abstract][Full Text] [Related]
2. [The clinico-instrumental evaluation of the efficacy of picotamide in treating chronic obstructive arteriopathies of the lower extremities].
Canonico V; Ammaturo V; Guarini P; Tedeschi C; Nunziata G; Nappi A; Forgione L; Rengo F
Minerva Cardioangiol; 1991 Mar; 39(3):75-80. PubMed ID: 1881558
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of arteriolar reactivity and blood coagulation parameters during picotamide treatment].
Saitta A; Bonaiuto M; Mileto A
Clin Ter; 1991 Oct 15-31; 139(1-2):9-16. PubMed ID: 1837769
[TBL] [Abstract][Full Text] [Related]
4. [Picotamide: use in chronic obliterative arteriopathies of the lower limbs].
Tazza G; Tazza R; Valentini M; Leoni G; Avenia N; Ragusa M
Clin Ter; 1991 Jun; 137(6):399-402. PubMed ID: 1832611
[TBL] [Abstract][Full Text] [Related]
5. Effect of long-term administration of picotamide on baseline and exercise-induced urinary albumin excretion in patients with type II diabetes mellitus and incipient nephropathy.
Giustina A; Ianniello P; Bossoni S; Comini MT; Desenzani P; Gazzoli N; Romanelli G
Clin Ther; 1994; 16(2):191-9. PubMed ID: 8062315
[TBL] [Abstract][Full Text] [Related]
6. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.
Neri Serneri GG; Coccheri S; Marubini E; Violi F;
Eur Heart J; 2004 Oct; 25(20):1845-52. PubMed ID: 15474700
[TBL] [Abstract][Full Text] [Related]
7. [Changes in morning platelet aggregation in patients with peripheral obliterating arteriopathy after evening administration of picotamide].
Craveri A; Colombo L; Cristina M; Coloru M; De Angeli B; Lanfredini M
Clin Ter; 1991 Jan; 136(1):23-9. PubMed ID: 1826869
[TBL] [Abstract][Full Text] [Related]
8. [Picotamide: prevention and therapy of diabetic vasculopathies. A double-blind clinical study].
Pibiri L; Petruzzo P; De Giudici A; Brotzu G
Clin Ter; 1990 May; 133(4):233-7. PubMed ID: 2142911
[TBL] [Abstract][Full Text] [Related]
9. Effect of picotamide and aspirin, combined or alone, on platelet aggregation in patients with cerebral infarction.
D'Andrea G; Perini F; Hasselmark L; Alecci M; Cananzi AR
Funct Neurol; 1995; 10(2):91-8. PubMed ID: 7557557
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy of picotamide].
de Falco FA; Montariello A; Mastroroberto G; Visconti OS
Clin Ter; 1991 Jul; 138(1):21-6. PubMed ID: 1834396
[TBL] [Abstract][Full Text] [Related]
11. Effects of picotamide, an antiplatelet agent, on cardiovascular, events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP study.
Milani M; Longoni A; Maderna M
Br J Clin Pharmacol; 1996 Dec; 42(6):782-5. PubMed ID: 8971437
[TBL] [Abstract][Full Text] [Related]
12. [Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen].
Landini G; Poggiali C; Calacoci S; Marino N; Rosselli A
Recenti Prog Med; 1989 Apr; 80(4):204-7. PubMed ID: 2762658
[TBL] [Abstract][Full Text] [Related]
13. Picotamide in migraine aura prevention: a pilot study.
Allais G; D'Andrea G; Airola G; De Lorenzo C; Mana O; Benedetto C
Neurol Sci; 2004 Oct; 25 Suppl 3():S267-9. PubMed ID: 15549555
[TBL] [Abstract][Full Text] [Related]
14. Picotamide versus aspirin in diabetic patients with peripheral arterial disease: has David defeated Goliath?
Gresele P; Migliacci R
Eur Heart J; 2004 Oct; 25(20):1769-71. PubMed ID: 15474690
[No Abstract] [Full Text] [Related]
15. Heparin-induced thrombocytopenia with arterial thrombosis: an unusual case.
Di Natale M; Fiusti R; Grassi M; Lai F; Corradi F
Haematologica; 1995; 80(3):246-7. PubMed ID: 7672719
[TBL] [Abstract][Full Text] [Related]
16. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
Maksimović ZV
Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
[TBL] [Abstract][Full Text] [Related]
17. Compliance of geriatric patients subjected to antiplatelet agents with Triflusal in peripheral arteriopathy. Preliminary data.
Zan S; Maselli M; Moniaci D; Varetto G; Ortensio M; Apostolou D; Comelli S; Scovazzi P
Minerva Cardioangiol; 2002 Jun; 50(3):263-70. PubMed ID: 12107407
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic, hemorheologic, and hemocoagulative changes after treatment with picotamide in patients affected by peripheral arterial disease (PAD) of the lower limbs.
Neirotti M; Molaschi M; Ponzetto M; Macchione C; Poli L; Bonino F; Fabris F
Angiology; 1994 Feb; 45(2):137-41. PubMed ID: 8129189
[TBL] [Abstract][Full Text] [Related]
19. The effect of picotamide on platelet function in patients with myeloproliferative disorders.
Rafanelli D; Grossi A; Vannucchi AM; Cinotti S; Morfini M; Ferrini PR
Thromb Haemost; 1990 Jun; 63(3):525-6. PubMed ID: 2402755
[No Abstract] [Full Text] [Related]
20. [The use of picotamide in nephropathy with mesangial IgA deposits. The effect on thromboxane generation].
Sagripanti A; Cupisti A; Giannessi D; Baicchi U; Bernini W; de Caterina R; Barsotti G
Clin Ter; 1993 Jan; 142(1):47-52. PubMed ID: 8472511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
